These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20729952)

  • 21. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
    Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
    Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutation in the MSH2 gene in Muir-Torre syndrome].
    Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F
    Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biallelic MYH germline mutations as cause of Muir-Torre syndrome.
    Guillén-Ponce C; Castillejo A; Barberá VM; Pascual-Ramírez JC; Andrada E; Castillejo MI; Guarinós C; Molina-Garrido MJ; Carrato A; Soto JL
    Fam Cancer; 2010 Jun; 9(2):151-4. PubMed ID: 19998059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case of Muir-Torre Syndrome.
    Sheth R; Menon P; Malik D
    Cureus; 2021 Apr; 13(4):e14582. PubMed ID: 34036002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Muir-Torre syndrome: a 25-year retrospect.
    Schwartz RA; Torre DP
    J Am Acad Dermatol; 1995 Jul; 33(1):90-104. PubMed ID: 7601953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
    Rütten A; Burgdorf W; Hügel H; Kutzner H; Hosseiny-Malayeri HR; Friedl W; Propping P; Kruse R
    Am J Dermatopathol; 1999 Oct; 21(5):405-13. PubMed ID: 10535567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muir-Torre Syndrome Presenting as Sebaceous Adenocarcinoma and Invasive MSH6-Positive Colorectal Adenocarcinoma.
    Tulpule S; Ibrahim H; Osman M; Zafar S; Kanta R; Shypula G; Islam MA; Sen S; Yousif A
    Case Rep Oncol; 2016; 9(1):95-9. PubMed ID: 26933426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
    Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
    J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case for diagnosis. Verrucous plaque on the pubic region.
    Silva DHM; Gouveia de Oliveira AK; Valente NYS; do Amaral Carneiro Cunha T
    An Bras Dermatol; 2021; 96(1):103-105. PubMed ID: 33288371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
    Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
    Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms.
    Schwartz RA; Goldberg DJ; Mahmood F; DeJager RL; Lambert WC; Najem AZ; Cohen PJ
    Dermatologica; 1989; 178(1):23-8. PubMed ID: 2917677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
    Karsten U; Christophers E; Sterry W
    Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muir-Torre syndrome.
    Lachiewicz AM; Wilkinson TM; Groben P; Ollila DW; Thomas NE
    Am J Clin Dermatol; 2007; 8(5):315-9. PubMed ID: 17902735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
    J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome.
    Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML
    Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sebaceous neoplasms in Muir-Torre syndrome.
    Misago N; Narisawa Y
    Am J Dermatopathol; 2000 Apr; 22(2):155-61. PubMed ID: 10770437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muir-Torre syndrome: case report and review of the literature.
    Ang JM; Alai NN; Ritter KR; Machtinger LA
    Cutis; 2011 Mar; 87(3):125-8. PubMed ID: 21488569
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.